SUSQUEHANNA INTERNATIONAL GROUP, LLP - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,080,883
+147.0%
90,756
+77.6%
0.00%
Q2 2023$842,606
-95.0%
51,098
-94.6%
0.00%
-100.0%
Q1 2023$16,736,685
-29.0%
938,155
+15.9%
0.00%
-50.0%
Q4 2022$23,565,127
+61.7%
809,242
+36.0%
0.01%
+50.0%
Q3 2022$14,573,000
+1918.4%
594,822
+241.9%
0.00%
Q2 2022$722,000
-54.6%
173,961
+26.2%
0.00%
Q1 2022$1,589,000
+23.6%
137,871
+6.9%
0.00%
Q4 2021$1,286,000
+85.0%
128,936
+142.3%
0.00%
Q3 2021$695,000
-36.9%
53,203
-5.4%
0.00%
Q2 2021$1,101,000
-66.8%
56,235
-63.9%
0.00%
Q1 2021$3,317,000
-78.2%
155,937
-69.5%
0.00%
-100.0%
Q4 2020$15,188,000
+416.6%
510,830
+276.5%
0.00%
Q3 2020$2,940,000
+1236.4%
135,666
+1273.8%
0.00%
Q2 2020$220,000
-7.9%
9,875
-37.1%
0.00%
Q1 2020$239,000
-48.9%
15,705
-27.6%
0.00%
Q3 2019$468,000
-28.7%
21,682
-27.4%
0.00%
Q2 2019$656,00029,8600.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 909,258$11,875,0002.75%
RA Capital Management 4,871,067$63,616,0000.88%
NEA Management Company, LLC 4,912,306$64,155,0000.76%
Samsara BioCapital, LLC 300,293$3,922,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,989,625$25,985,0000.51%
Baker Brothers Advisors 3,863,239$50,454,0000.22%
ACT CAPITAL MANAGEMENT, LLC 31,000$405,0000.21%
Rock Springs Capital Management LP 612,180$7,995,0000.17%
GILDER GAGNON HOWE & CO LLC 1,496,424$19,543,0000.10%
FEDERATED HERMES, INC. 3,011,053$39,324,0000.08%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders